PuraCath UV Device Displays a 99.9999% Disinfection of COVID-19 Virus in 1 Second

puracath • April 27, 2020

PuraCath has been partnered and working with a top tier BSL-3 National Laboratory, which has a premiere high containment infectious disease facilities to test its Firefly UV device for the ICU and hospitals with 2019-nCoV (the COVID-19 virus).

The preliminary results show that PuraCath’s device has achieved 99.9999% disinfection with SARS-CoV-2 (the virus that is known to cause COVID-19) in just one second. The Firefly UV device can help reduce nurse-to-patient, patient-to-patient, or patient-to-nurse viral transmission in the ICU settings in hospitals. Moreover, in a rapidly paced environment like the ICU, it is critical to be able to disinfect fast and efficiently, like with Firefly.

“We are very excited with this recent partnership with a prestigious National Laboratory and news on rapid disinfection of the COVID-19 virus on our device. We believe that the Firefly can bring substantial clinical benefits and reduced infection transmission in critically ill patients in ICUs and hospitals worldwide,” states Ms. Julia Rasooly, CEO and Founder of PuraCath Medical.

< Older Post

Newer Post >

How UV Disinfection is Transforming Infection Prevention in Medical Settings

October 10, 2024

PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced today that it has published the result of its research on its ultraviolet (UV) light-based intravascular catheter connection disinfection system in the American Journal of Infection Control (AJIC), a peer-reviewed scientific journal published by Elsevier on behalf of the Association for Professionals in Infection Control and Epidemiology.

Disinfection of needleless connectors for catheters in one second using a hand-held UV device

October 9, 2024

Central Line-associated Bloodstream Infections (CLABSIs) are deadly bloodstream infections with high mortality and morbidity rates in patients with vascular catheters. In the United States, around 250,000 occur yearly. Of these, about 80,000 occur in intensive care units.

PuraCath Medical Receives 510(k) Clearance for its Needleless Connector for Vascular Access

By puracath • August 3, 2021

Device is intended for use primarily by ICU nurses during infusions in patients in a critical care setting. PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced today that it has received 510(k) clearance for its FireFly™ Needleless Connector from the U.S. Food […]

Why We Aren’t Using UV to Disinfect Everything—Yet

By puracath • June 16, 2020

Negative perception and costs pose obstacles to a promising technology As the coronavirus pandemic continues, a technology that has existed for over 100 years is getting renewed attention as a promising disinfection tool. Ultraviolet germicidal radiation, which uses short-wavelength UV rays to kill bacteria and viruses, is already used to disinfect the air, water, and […]

PuraCath FireflyTM Can Kill Deadly Microorganisms with UV Light, Like SARS CoV-2

By puracath • March 19, 2020

President Trump has officially declared a national emergency. A novel coronavirus has been identified in Wuhan City, China and has spread worldwide. It has been named SARS CoV-2 (causing disease COVID-19) by WHO. SARS CoV-2 has officially become a global pandemic by WHO. There have already been over 170,000 confirmed cases to date with an […]

PuraCath Medical Shows Greater Than 99.99% Reduction in ‘Superbug’ Candida Auris with One Second of UVC Exposure

By puracath • June 19, 2019

JUNE 18, 2019 PuraCath Medical, a venture-backed medical device company based in Silicon Valley, announced today that it has achieved 99.99% disinfection on its vascular access Firefly disinfection technology system with Candida auris (‘superbug’), Staphylococcus aureus, and Candida albicans. “Achieving greater than 4 log disinfection in these virulent microbes with only one second of UV […]

PuraCath Medical Shows Significant Reduction in Causes of Peritonitis in Peritoneal Dialysis International Journal

By puracath • March 7, 2017

San Francisco, California (March 7, 2017) – PuraCath Medical has published the result of its recent research on its ultraviolet (UV) light-based peritoneal dialysis catheter connection system in Peritoneal Dialysis International (PDI), the official Journal of the International Society for Peritoneal Dialysis. PDI is a major source of knowledge in the field of peritoneal dialysis and aims […]

PuraCath Medical to Present Data on FireFly™ Peritoneal Dialysis Connector Disinfecting System during 53rd ERA-EDTA Congress

By Larry Yost • May 12, 2016

San Francisco, California (May 12, 2016) – Data being presented will support planned introduction of PuraCath Medical’s technology in the European Union. PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it will present data on its next generation version of the FireFly™ […]

PuraCath Medical Presents Data at National Kidney Foundation 2016 Spring Clinical Meetings

By Larry Yost • April 28, 2016

Boston, Massachusetts (April 28, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of the FireFly™ Peritoneal Dialysis (PD) Connector Disinfecting System during the National Kidney Foundation’s 2016 Spring Clinical Meetings held […]

PuraCath Medical Presents New Research Data during 36th Annual Dialysis Conference

By Larry Yost • February 29, 2016

Company presents study on the effectiveness of next-generation version of the FireFly™ Peritoneal Dialysis Connector Disinfecting System Seattle, Washington (February 29, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of […]

site by: Deco